Company News

05/17/2022

Governor Youngkin Announces Expansion of Life Sciences in Prince William County, Creating up to 70 New Jobs

~ Virongy Biosciences Inc. to invest $471,000 to begin development of diagnostic technologies for viral pathogens ~ RICHMOND, VA – Governor Glenn Youngkin announced that Virongy Biosciences Inc., a developer of viral diagnostic technologies, anti-viral drugs, and therapeutic viral vectors, will invest $471,000 to expand in Prince William County. The company recently relocated to occupy over

05/11/2022

UVA Health, Focused Ultrasound Foundation Partner to Create World’s First Focused Ultrasound Cancer Immunotherapy Center

$8 Million Investment to Fund Cutting-Edge Research, Launch Clinical Trials, Create Jobs Charlottesville, VA – UVA Health and the Charlottesville-based Focused Ultrasound Foundation today announced the launch of the Focused Ultrasound Cancer Immunotherapy Center, the world’s first center dedicated specifically to advancing a focused ultrasound and cancer immunotherapy treatment approach that could revolutionize 21st-century cancer

05/10/2022

Germany’s BfArM Approves ReAlta Life Sciences’ Phase 1b Study

Inhaled LPS Challenge Trial to Support Development of RLS-0071 in Severe Asthma RLS-0071 is ReAlta’s lead dual action complement inhibitor and innate anti-inflammatory peptide in development as a treatment for hypoxic ischemic encephalopathy, severe asthma, and other rare diseases Norfolk, VA, – ReAlta Life Sciences (“ReAlta”), Inc., a clinical stage, rare disease company dedicated to harnessing

05/04/2022

GRP named a top economic development organization in the U.S.

RICHMOND, VA – The Greater Richmond Partnership (GRP) was named among the top 20 economic development organizations in the nation according to Site Selection magazine, a national publication targeting site location professionals and corporate executives making relocation decisions. The 2022 Mac Conway Awards for Excellence in Economic Development, named in honor of Site Selection founding publisher

05/03/2022

BIO-CAT Publishes Foundational Study of Digestive Enzyme Function

TROY, Va.,/PRNewswire/ — A clinical trial designed by BIO-CAT, Inc – a biotech company specializing in enzyme development – studied the use of enzymes to improve digestion in an in vitro model of aging. The results showed that a multi-component supplemental enzyme blend (microbial proteases, lipase, amylase, and glucoamylase) effectively released nutrients from a balanced meal better

04/27/2022

Richmond medical technology company raises $1M

Richmond medical technology company Tympanogen Inc. has raised $1 million in fresh funding, according to a Securities and Exchange Commission filing. Tympanogen raised the money from 12 investors and said it is seeking to raise up to $2.5 million through debt and other options, according to the March filing. The round includes participation from Williamsburg’s ShockVentures

04/25/2022

Euclid Vision Announces Acquisition of Visionary Optics

Euclid Vision Corp., a global leader in advanced orthokeratology and proactive myopia management initiatives, is pleased to announce its acquisition of Visionary Optics, a specialty scleral contact lens design and distribution pioneer. The acquisition signifies Euclid’s recognition of the value of joining forces with Visionary Optics, the only company in the US that concentrates almost

04/22/2022

Virginia Bio Announces Recipients of its 2022 Outstanding Contributions to Bioscience Award

Dr. Richard T. Marconi of VCU and Jeff Gallagher, former Virginia Bio CEO, are recognized for their outstanding contributions to the biosciences in the Commonwealth.   Richmond, VA, (April 22) – Every two years, the Virginia Biotechnology Association recognizes individual Virginians for their significant contributions to bioscience and the Virginia biotechnology ecosystem.  This year, Dr.

04/17/2022

Merck opens Virginia plant to support UNICEF deal for HPV vaccines

Elkton, VA (EndpointNews) – A construction project built around expanding the vaccine manufacturing capabilities at a Merck site in Elkton, VA, has been completed. The upgrades will support the company’s human papillomavirus vaccine, Gardasil 9, once it gains review and approval from regulators. About 150 new jobs have been added to the site, as the

04/08/2022

Virginia Western to launch new 2-year biotechnology degree

Roanoke, VA (The Roanoke Times) – Virginia Western Community College announced this week it will be launching a new biotechnology degree program to keep pace with the region’s fast-growing industry. Students will earn a two-year associate degree in biotechnology that will prepare them to transfer to a four-year school for a bachelor’s degree or to

04/06/2022

ATCC Announces Expansion of its Bioinformatics Data Platform with QIAGEN

ATCC’s collection of high-fidelity, authenticated DNA-seq and RNA-seq datasets to be included in QIAGEN’s databases for biotechnology and pharmaceutical companies for research Manassas, VA, United States, ATCC, the world’s premier biological materials management and standards organization, today announced that it has entered into an agreement with QIAGEN, a recognized leader in bioinformatics solutions, to provide

04/05/2022

Governor Glenn Youngkin Announces Sports Medicine Company to Expand in the City of Norfolk, Creating 92 New Jobs

RICHMOND, VA  (Office of Governor Glenn Youngkin) – Governor Glenn Youngkin today announced that Embody, Inc., a Norfolk-based medical device company developing novel collagen-based technologies for soft tissue repair, will invest $5 million to expand its headquarters at Innovation Research Park at Old Dominion University in the City of Norfolk. The company will add 10,000

03/25/2022

One of World’s Top Innovators Joins Focused Ultrasound Foundation as Chief Technology Officer

Charlottesville, Va., – Rick Hamilton, a leading inventor and authority on technology and innovation, has joined the Foundation as Managing Director and Chief Technology Officer. Hamilton is the one of the world’s most prolific inventors with more than 1,040 patents, standing just behind Thomas Edison. He has spent nearly 30 years at Fortune 50 organizations and

03/22/2022

Carilion Clinic, Richmond firm part of $3.5M concussion grant

Clinical trial to follow 300 patients Roanoke, VA (Virginia Business) – Roanoke-based Carilion Clinic and Richmond’s BRAINBox Solutions Inc. are part of a $3.5 million National Institutes of Health grant to research and develop a new way to diagnose brain injuries in the elderly. The research will include enrolling 300 patients with head trauma and

03/16/2022

ZielBio Announces First Patient Dosed in Phase 1/2 Clinical Trial of ZB131, Its Novel Monoclonal Antibody Targeting Cancer Specific Plectin

First-in-human, open-label, dose escalation study will evaluate ZB131 in patients who have solid tumors with high CSP expression ZB131 clinical trial open and enrolling patients CHARLOTTESVILLE, Va./PRNewswire/ — ZielBio, Inc., a clinical stage biotechnology company discovering new treatments for cancer through its innovative ZielFind drug discovery platform, today announced the first patient dosed in its

03/14/2022

VIPC Regional Innovation Fund Grant Awarded to Charlottesville BioHub to Strengthen the Entrepreneurial Ecosystem in the Charlottesville Region

Funding will further Charlottesville BioHub’s goals to advance entrepreneurship in the area’s biotechnology sector and support tech and other innovation-led sectors with resourcing and connection Charlottesville, Virginia – Charlottesville BioHub, an industry-led 501c3 nonprofit organization dedicated to strengthening Charlottesville’s biotechnology industry sector, today announced that it has received a $200,000 grant from the Virginia Innovation Partnership Corporation’s

03/10/2022

Virginia Tech and Amazon establish machine learning research partnership

Virginia Tech and Amazon are partnering to advance research and innovation in artificial intelligence and machine learning. The Amazon – Virginia Tech Initiative for Efficient and Robust Machine Learning will include machine learning-focused research projects, doctoral student fellowships, community outreach, and an establishment of a shared advisory board. “This partnership affirms the value of our

03/09/2022

Phlow Launches Key Essential Medicines to Leading Children’s Hospitals to Help Alleviate Impact of Shortages

RICHMOND, Va.–(BUSINESS WIRE)–Phlow, a U.S.-based, public benefit impact-driven pharmaceutical company, announced the launch of key essential medicines, sequentially over the coming quarter, for the Children’s Hospital Coalition™ (CHC), a first-in-kind coalition of leading pediatric institutions. The availability of these medications is an important first step demonstrating Phlow’s commitment to CHC members to provide a reliable

03/03/2022

BIO-CAT Microbials Invests $35 Million in State-of-the-Art Virginia Fermentation Facility

TROY, Va.,  /PRNewswire/ — BIO-CAT Microbials, LLC — a Virginia-based leading microbial solutions company — recently announced a $35 million investment to significantly expand its Troy, Virginia facility to include fermentation capabilities. The company will be breaking ground on an initial 53,800 square-foot expansion phase in March of 2022, with potential future expansion up to an additional 100,000 square feet. The expansion

03/03/2022

Civica to Manufacture and Distribute Affordable Insulin

Americans with diabetes will have access to more affordable insulins through a transparent, cost-plus model Drastically reducing out-of-pocket costs for insulin through transformative collaboration between Civica and dedicated partners representing nearly every corner of the diabetes ecosystem LEHI, Utah –(BUSINESS WIRE)–Civica, Inc. (Civica, Civica Rx) today announced plans to manufacture and distribute insulins that, once

03/02/2022

FDA Approves Kaléo’s 10 mg Naloxone Auto-Injector for the Treatment of Known or Potential Exposure to Ultra-Potent Weaponized Opioids

Product Received Fast-Track Designation for military personnel facing the potential threat of exposure to synthetic opioids on the battlefield on behalf of the U.S. Department of Defense. RICHMOND, Va.–(BUSINESS WIRE)–Kaléo, a privately held U.S. pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Naloxone Auto-injector 10 mg (NALOXONE HYDROCHLORIDE

03/02/2022

Tom Ryder Joins Focused Ultrasound Foundation Board of Directors

CHARLOTTESVILLE, VA – Thomas O. Ryder, an investor, entrepreneur, and retired corporate executive, was elected to the Focused Ultrasound Foundation’s Board of Directors at their March 1 meeting. Ryder has served as Chairman and CEO of the Reader’s Digest Association and President of American Express’s Travel Related Services International, Merchant Services Worldwide, and American Express Publishing

02/28/2022

Pharma Cluster Accelerator Announces New Diversity, Equity and Inclusion Lead

New position ensures access to opportunities created by the Advanced Pharmaceutical Research and Manufacturing Cluster regardless of race, ethnicity, gender, or geographic location. Richmond, VA –  The Cluster Accelerator for Advanced Pharmaceutical Research and Manufacturing, an entity launched to fast-track the development of a globally competitive essential medicines manufacturing hub across Central Virginia, announced the hiring

02/25/2022

Lighthouse Labs Announces Newest Cohort

Three Richmond-area companies — a maker of ingredient-conscious lipstick and lip balms, a company that helps connect expectant and new parents to care providers, and a firewood delivery service — were selected to participate in a Richmond accelerator program for startup companies. The three Richmond businesses will join six others — including two from elsewhere